Global study tests how well popular COPD treatment works in everyday life
NCT ID NCT07069829
Summary
This study follows 1,400 adults with moderate to severe COPD who are starting treatment with Breztri/Trixeo, a triple-therapy inhaler. Researchers will track how patients feel and function over 12 months in real-world medical settings across Latin America, Asia, and the Middle East/Africa. The goal is to understand how this already-approved treatment affects daily life, symptom control, and quality of life outside of controlled clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGAlexandria, Egypt
-
Research Site
RECRUITINGCairo, Egypt
-
Research Site
NOT_YET_RECRUITINGCairo, Egypt
-
Research Site
RECRUITINGAbhā, Saudi Arabia
-
Research Site
RECRUITINGRiyadh, Saudi Arabia
-
Research Site
RECRUITINGYunlin, Taiwan, Taiwan
-
Research Site
RECRUITINGTaichung, Taiwan
-
Research Site
RECRUITINGTainan, Taiwan
-
Research Site
RECRUITINGTaipei, Taiwan
-
Research Site
RECRUITINGHà Nội, Vietnam, Vietnam
-
Research Site
NOT_YET_RECRUITINGHà Nội, Vietnam, Vietnam
-
Research Site
RECRUITINGHo Chi Minh City, Vietnam
Conditions
Explore the condition pages connected to this study.